Current Affairs - Technology - Discussion

India has developed Nafithromycin, its first homegrown antibiotic, aimed at treating resistant respiratory infections, especially in vulnerable patients. This achievement, alongside successful indigenous gene therapy trials for hemophilia, underscores India’s growing capabilities in biotechnology, pharmaceutical innovation, and clinical research. These breakthroughs were enabled by collaborations between the Department of Biotechnology and private firms like Wockhardt, reflecting a strong public-private partnership. Additionally, India’s progress in genome sequencing and precision medicine positions the country as a rising leader in healthcare innovation, reducing dependence on foreign technologies and advancing its goal of biotech self-reliance under the Viksit Bharat 2047 vision.